Considering the role of health economics in pyoderma gangrenosum and other dermatology research

N Bray

doi:10.1111/bjd.15767

Considering the role of health economics in pyoderma gangrenosum and other dermatology research

N Bray

School of Health Sciences

Centre for Health Economics and Medicines Management Evaluation

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	1475-1476
Journal	British Journal of Dermatology
Volume	177
Issue number	6
DOIs	https://doi.org/10.1111/bjd.15767
Publication status	Published - Dec 2017

Keywords

Cost-Benefit Analysis
Cyclosporine
Dermatology
Humans
Prednisolone
Pyoderma Gangrenosum

Access to Document

10.1111/bjd.15767

Cite this

@article{8f1229e79ee0451eb5660851f9feece3,

title = "Considering the role of health economics in pyoderma gangrenosum and other dermatology research",

keywords = "Cost-Benefit Analysis, Cyclosporine, Dermatology, Humans, Prednisolone, Pyoderma Gangrenosum",

author = "N Bray",

year = "2017",

month = dec,

doi = "10.1111/bjd.15767",

language = "English",

volume = "177",

pages = "1475--1476",

journal = "British Journal of Dermatology",

issn = "1365-2133",

publisher = "Oxford University Press",

number = "6",

}

TY - JOUR

T1 - Considering the role of health economics in pyoderma gangrenosum and other dermatology research

AU - Bray, N

PY - 2017/12

Y1 - 2017/12

KW - Cost-Benefit Analysis

KW - Cyclosporine

KW - Dermatology

KW - Humans

KW - Prednisolone

KW - Pyoderma Gangrenosum

U2 - 10.1111/bjd.15767

DO - 10.1111/bjd.15767

M3 - Article

C2 - 29313936

SN - 1365-2133

VL - 177

SP - 1475

EP - 1476

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 6

ER -